Key Insights

Highlights

Success Rate

33% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

44.4%

4 terminated out of 9 trials

Success Rate

33.3%

-53.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results33% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (8)

Trial Status

Terminated4
Completed2
Not Yet Recruiting1
Recruiting1
Unknown1

Trial Success Rate

33.3%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (9)

Research Network

Activity Timeline